DOCETAXEL - CURRENT STATUS AND FUTURE-PROSPECTS

被引：19

作者：

EISENHAUER, EA

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1995年 / 13卷 / 12期

关键词：

D O I：

10.1200/JCO.1995.13.12.2865

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：2865 / 2868

页数：4

相关论文

共 35 条

[1]

AAMDAL S, 1990, EUR J CANCER, V65, P2478

[2] PACLITAXEL ACTIVITY IN HEAVILY PRETREATED BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE TREATMENT REFERRAL CENTER TRIAL [J].

ABRAMS, JS ;

VENA, DA ;

BALTZ, J ;

ADAMS, J ;

MONTELLO, M ;

CHRISTIAN, M ;

ONETTO, N ;

DESMONDHELLMANN, S ;

CANETTA, R ;

FRIEDMAN, MA ;

ARBUCK, SG .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2056-2065

[3] PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY [J].

BEDIKIAN, AY ;

WEISS, GR ;

LEGHA, SS ;

BURRIS, HA ;

ECKARDT, JR ;

JENKINS, J ;

ETON, O ;

BUZAID, AC ;

SMETZER, L ;

VONHOFF, DD ;

BENJAMIN, RS .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2895-2899

[4]

BISSETT D, 1993, CANCER RES, V53, P523

[5] PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR 6-HOUR INTRAVENOUS-INFUSION [J].

BURRIS, H ;

IRVIN, R ;

KUHN, J ;

KALTER, S ;

SMITH, L ;

SHAFFER, D ;

FIELDS, S ;

WEISS, G ;

ECKARDT, J ;

RODRIGUEZ, G ;

RINALDI, D ;

WALL, J ;

COOK, G ;

SMITH, S ;

VREELAND, F ;

BAYSSAS, M ;

LEBAIL, N ;

VONHOFF, D .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :950-958

[6] DOCETAXEL (TAXOTERE(R)) - AN ACTIVE-DRUG FOR THE TREATMENT OF PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].

CATIMEL, G ;

VERWEIJ, J ;

MATTIJSSEN, V ;

HANAUSKE, A ;

PICCART, M ;

WANDERS, J ;

FRANKLIN, H ;

LEBAIL, N ;

CLAVEL, M ;

KAYE, SB .

ANNALS OF ONCOLOGY, 1994, 5 (06) :533-537

[7] DOCETAXEL (TAXOTERE(TM)) IS ACTIVE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL OF THE EORTC EARLY CLINICAL-TRIALS GROUP (ECTG) [J].

CERNY, T ;

KAPLAN, S ;

PAVLIDIS, N ;

SCHOFFSKI, P ;

EPELBAUM, R ;

VANMEERBEEK, J ;

WANDERS, J ;

FRANKLIN, HR ;

KAYE, S .

BRITISH JOURNAL OF CANCER, 1994, 70 (02) :384-387

[8] DOCETAXEL IS A MAJOR CYTOTOXIC DRUG FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE CLINICAL SCREENING COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER [J].

CHEVALLIER, B ;

FUMOLEAU, P ;

KERBRAT, P ;

DIERAS, V ;

ROCHE, H ;

KRAKOWSKI, I ;

AZLI, N ;

BAYSSAS, M ;

LENTZ, MA ;

VANGLABBEKE, M .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :314-322

[9]

DIERAS V, 1994, P AN M AM SOC CLIN, V13, P78

[10]

EINZIG AI, 1994, P AN M AM SOC CLIN, V13, P395

← 1 2 3 4 →